Medicare Enrolled
Dr. Adnan Afzal, M.D.
Cardiovascular Disease · Conroe, TX
Practice pattern: Remote Monitoring
— Significant remote device monitoring activity
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Afzal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Afzal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Afzal
Dr. Adnan Afzal is a cardiovascular disease specialist in Conroe, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Afzal performed 9,877 Medicare services across 3,528 unique beneficiaries.
Between the years covered by Open Payments, Dr. Afzal received a total of $14,650 from 48 pharmaceutical and/or device companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Afzal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in TX
$14,650 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,877
Medicare services
Top 3% in TX for cardiovascular disease
3,528
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~520 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
2,352 | $31 | $118 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
1,476 | $37 | $145 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,279 | $38 | $159 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
900 | $10 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
660 | $93 | $378 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
607 | $61 | $267 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
396 | $43 | $70 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
202 | $138 | $502 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
170 | $36 | $650 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
167 | $16 | $68 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
158 | $50 | $209 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
155 | $14 | $54 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 139 | $311 | $1,612 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
132 | $21 | $88 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
118 | $28 | $400 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
96 | $20 | $77 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
91 | $138 | $488 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
85 | $331 | $1,165 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
68 | $1,075 | $3,215 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
65 | $138 | $561 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
58 | $91 | $356 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $89 | $374 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
46 | $52 | $224 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
46 | $59 | $209 |
| Radiofrequency vein destruction, first vein A procedure to treat the first incompetent vein in the arm or leg using radiofrequency energy and imaging guidance. |
40 | $832 | $3,292 |
| New patient office visit, complex (60-74 min) | 40 | $142 | $646 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $108 | $485 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
34 | $27 | $110 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
29 | $57 | $246 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
28 | $185 | $722 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
27 | $639 | $2,609 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
26 | $18 | $75 |
| Cardiac catheterization | 23 | $189 | $840 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $38 | $165 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
18 | $10 | $149 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
17 | $93 | $297 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $85 | $327 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.9% high complexity
11.3% medium
82.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,650
Total received (2018-2024)
Avg $2,093/year across 7 years
Top 24% in TX for cardiovascular disease
48
Companies
749
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,650 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,712
2023
$2,833
2022
$2,061
2021
$1,959
2020
$1,159
2019
$2,158
2018
$2,769
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,049
Amgen Inc.
$1,898
Abbott Laboratories
$1,395
Medtronic Vascular, Inc.
$1,164
Boston Scientific Corporation
$1,084
Medtronic, Inc.
$895
BIOTRONIK INC.
$763
Janssen Pharmaceuticals, Inc
$444
E.R. Squibb & Sons, L.L.C.
$400
Boehringer Ingelheim Pharmaceuticals, Inc.
$382
Esperion Therapeutics, Inc.
$315
AstraZeneca Pharmaceuticals LP
$303
Merck Sharp & Dohme LLC
$254
Impulse Dynamics (USA) Inc.
$249
SANOFI-AVENTIS U.S. LLC
$246
PFIZER INC.
$237
Gilead Sciences, Inc.
$235
BOSTON SCIENTIFIC CORPORATION
$234
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$230
Biosense Webster, Inc.
$227
Amarin Pharma Inc.
$206
Chiesi USA, Inc.
$204
Venclose Inc.
$196
Baxter Healthcare
$142
Tactile Systems Technology Inc
$128
Regeneron Healthcare Solutions, Inc.
$120
HeartFlow, Inc.
$98
CVRx, Inc.
$95
Philips Electronics North America Corporation
$63
Bayer HealthCare Pharmaceuticals Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$42
Bardy Diagnostics, Inc.
$27
Astellas Pharma US Inc
$25
Braemar Manufacturing, LLC
$24
AGEPHA Pharma FZ LLC
$23
Kestra Medical Technology Services, Inc.
$22
Lexicon Pharmaceuticals, Inc.
$19
ZOLL Circulation Inc
$19
Kowa Pharmaceuticals America, Inc.
$17
Philips North America LLC
$17
Cleerly, Inc.
$16
AngioDynamics, Inc.
$16
Cook Medical LLC
$15
Bard Peripheral Vascular, Inc.
$15
Resmed Corp
$15
Allergan Inc.
$14
Siemens Medical Solutions USA, Inc.
$14
Actelion Pharmaceuticals US, Inc.
$11
Top 3 companies account for 36.5% of total payments
Associated products mentioned in payments ›
(CK4) MCOT · AMPLATZER AMULET · AMPLATZER TALISMAN · AirMini · Assure WCD · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CareLink · Carnation Ambulatory Monitor · Claria MRI · Cleerly Ischemia · ClosureFast · Confirm Rx · CorPath GRX · Corlanor · DIAMONDBACK PERIPHERAL · ELIQUIS · ENTRESTO · EVRSF · Edarbi · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLEXITOUCH · Flexitouch Plus · GENERAL - THROMBECTOMY · GENERAL - VASCULAR INTERVENTION · HawkOne · HeartMate 3 Left Ventricular Assist Device · Hillrom - Carnation Ambulatory Monitor · IN.PACT Admiral · Ingenia 1.5T R4 · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LODOCO · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MULTAQ · Mitra Clip system · NAVITOR · NEXLETOL · OCTARAY MAPPING CATHETER · OPSUMIT · OPTIMIZER · Optimizer · Optimizer Smart System · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim IPG · QUADRA ASSURA · RESONATE · REVEAL LINQ · Ranexa · Repatha · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Temperature Management System · TurboHawk · VENASEAL · VERQUVO · Vascepa · VenaCure 1470 Pro · VenaSeal · Verquvo · ViewFlex Xtra ICE Catheter · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZILVER PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $148 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
85
Per 100K population
13.0
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Afzal is a remote monitoring specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Afzal experienced with remote vital sign monitoring management, each additional 20 minutes?
Based on Medicare claims data, Dr. Afzal performed 2,352 remote vital sign monitoring management, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Afzal receive payments from pharmaceutical companies?
Yes. Dr. Afzal received a total of $14,650 from 48 companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Afzal's costs compare to other cardiologists in Conroe?
Dr. Afzal's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Afzal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Conroe
Browse cardiologists in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology